Cargando…

The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis

BACKGROUND: Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions. OBJECTIVES: To determine if CBD/CBDA is an effective therapy for canine atopic dermatitis (cAD). ANIMALS: Thirty‐two privately owned dogs with cAD. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loewinger, Melissa, Wakshlag, Joseph J., Bowden, Daniel, Peters‐Kennedy, Jeanine, Rosenberg, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Hypersensitivity Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543248/ https://www.ncbi.nlm.nih.gov/pubmed/35644533 http://dx.doi.org/10.1111/vde.13077

Ejemplares similares

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis
por: Van Brussel, Leen, et al.
Publicado: (2021)

Altered plasma cytokines in dogs with atopic dermatitis
por: Mazrier, Hamutal, et al.
Publicado: (2021)

Serum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis
por: Asahina, Ryota, et al.
Publicado: (2020)

A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine‐month controlled study
por: Watson, Adrian, et al.
Publicado: (2021)

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases
por: Fennis, Evelien E. M., et al.
Publicado: (2022)

An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs
por: Favrot, Claude, et al.
Publicado: (2021)

Evaluation of the theoretical risk of cross‐reactivity among recently identified food allergens for dogs
por: Olivry, Thierry, et al.
Publicado: (2022)

Detection and Inhibition of IgE for cross‐reactive carbohydrate determinants evident in an enzyme‐linked immunosorbent assay for detection of allergen‐specific IgE in the sera of dogs and cats
por: Lee, Kenneth W., et al.
Publicado: (2020)

The usefulness of a hydrolysed fish and rice starch elimination diet for the diagnosis of adverse food reactions in cats: an open clinical trial
por: Noli, Chiara, et al.
Publicado: (2021)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
por: Garcia, Gabriel A., et al.
Publicado: (2022)

Dermatological evaluation in dogs with atopic dermatitis treated with full-spectrum high cannabidiol oil: a pre study part 1
por: Mariga, Carollina, et al.
Publicado: (2023)

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
por: Gamble, Lauri-Jo, et al.
Publicado: (2018)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Evaluation of the efficacy of a cannabidiol and cannabidiolic acid rich hemp extract for pain in dogs following a tibial plateau leveling osteotomy
por: Klatzkow, Sarah, et al.
Publicado: (2023)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
por: Kitamura, Masashi, et al.
Publicado: (2020)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Cannabidiol Oil-Associated Microscopic Colitis
por: Oruganti, Poornima, et al.
Publicado: (2020)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015)

Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis
por: Massimini, Marcella, et al.
Publicado: (2021)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
por: Wakshlag, Joseph J., et al.
Publicado: (2020)

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013)

Oropharyngeal Bleeding Due to Cannabidiol Oil Vape Use
por: Pankhania, Rahul, et al.
Publicado: (2021)

Change in Refractive Error Associated With the Use of Cannabidiol Oil
por: Ali, Amir, et al.
Publicado: (2021)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion
por: Boggs, Douglas Lee, et al.
Publicado: (2016)

Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge
por: Di Salvo, Alessandra, et al.
Publicado: (2023)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
por: Fortin, Davide, et al.
Publicado: (2021)

Cannabidiolic acid in Hemp Seed Oil Table Spoon and Beyond
por: Nigro, Ersilia, et al.
Publicado: (2022)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.
por: Martinenghi, Laura Daniela, et al.
Publicado: (2020)

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
por: Umpierrez, Laísa S., et al.
Publicado: (2022)

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol
por: Storozhuk, Maksim V.
Publicado: (2023)

Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
por: Polidoro, Dakir, et al.
Publicado: (2022)

Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs
por: Bradley, Sophie, et al.
Publicado: (2022)

Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
por: della Rocca, Giorgia, et al.
Publicado: (2023)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ftkjufuu7j1qlg82cbfuotkt2h